The Optimal Concentration of Ropivacaine in Combination with Butorphanol 50micro gram/ml for Patient-Controlled Epidural Analgesia
Dong Hee Kim
Abstract
Open-access reader
Dong Hee Kim
Abstract
Open-access reader
Background: Opioids may be used in a dose-sparing capacity with local anesthetics to reduce the dose needed.This study examined the efficacy of different concentrations of ropivacaine combined with butorphanol 50μg/ml to provide postoperative analgesia.Methods: Sixty parturients were received epidural infusion with 0.075% ropivacaine (Group 1: n = 20), 0.1% ropivacaine (Group 2: n = 20) and 0.15% ropivacaine (Group 3: n = 20) in combination with butorphanol 50μg/ml using patient-controlled epidural analgesia (PCEA) after cesarean section.PCEA was started with basal infusion of 4 ml of PCEA solution and 4 ml of bolus infusion at 10 min of lockout interval.Using a visual analogue scale (VAS) assessed the degree of pain and incidences of side effects were checked.Results: Total infusion doses of ropivacaine were significantly higher in group 3, and butorphanol consumption were significantly lower in group 3 (P < 0.05).The incidences of nausea, vomiting and sedation were significantly higher in group 1 (P < 0.05).There were no significantly differences in VAS pain score and other side effects among the groups.Conclusions: This study suggests that 0.1% or 0.15% ropivacaine with butorphanol 50μg/ml for PCEA can provide the most effective analgesia with less side effects after cesarean section.(Korean J Anesthesiol 2002; 43: 749∼754)
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Background: Opioids may be used in a dose-sparing capacity with local anesthetics to reduce the dose needed.This study examined the efficacy of different concentrations of ropivacaine combined with butorphanol 50μg/ml to provide postoperative analgesia.Methods: Sixty parturients were received epidural infusion with 0.075% ropivacaine (Group 1: n = 20), 0.1% ropivacaine (Group 2: n = 20) and 0.15% ropivacaine (Group 3: n = 20) in combination with butorphanol 50μg/ml using patient-controlled epidural analgesia (PCEA) after cesarean section.PCEA was started with basal infusion of 4 ml of PCEA solution and 4 ml of bolus infusion at 10 min of lockout interval.Using a visual analogue scale (VAS) assessed the degree of pain and incidences of side effects were checked.Results: Total infusion doses of ropivacaine were significantly higher in group 3, and butorphanol consumption were significantly lower in group 3 (P < 0.05).The incidences of nausea, vomiting and sedation were significantly higher in group 1 (P < 0.05).There were no significantly differences in VAS pain score and other side effects among the groups.Conclusions: This study suggests that 0.1% or 0.15% ropivacaine with butorphanol 50μg/ml for PCEA can provide the most effective analgesia with less side effects after cesarean section.(Korean J Anesthesiol 2002; 43: 749∼754)
Key concepts: Ropivacaine, Butorphanol, Gram, Medicine, Anesthesia, Geology, Paleontology, Bacteria